Create your own free news widgets.

Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that a Phase III study (RIBBON 2) of Avastin® (bevacizumab) in combination with chemotherapy increased the time women with metastatic HER2-negative breast cancer whose initial chemotherapy had stopped working lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone.

EDMONTON, ALBERTA--(Marketwire - Aug. 18, 2009) - Innovotech Inc. (TSX VENTURE:IOT) today announced its unaudited financial and operational results for the three and six month periods ended June 30, 2009. Highlights: - Company shows revenue increase over second quarter 2008. - Positive clinical outcomes demonstrated for bioFILM PA - Company maintains healthy cash reserve 'The Company has maintained its product development momentum through an increase in contract revenue in the second quarter and continuing strong cash reserves' say Dr. James Timourian, Chief Financial Officer of Innovotech. 'bioFILM PA has achieved another milestone with the demonstration of positive clinical outcomes in use in cystic fibrosis patients (see www.innovotech.ca for more detail). Agress continues to show promise in an expanding portfolio of crop and disease uses while awaiting regulatory approval. Evaluation and licensing discussion have continued with several multinational agriculture compa

A negative or inhibited personality type (type D personality) appears to be associated with an increased risk of death among individuals with peripheral artery disease. Peripheral artery disease (PAD) is atherosclerosis, or plaque buildup in arteries that supply the extremities. The report is found in the in ... ...

The increasing popularity of excessive forms of exercise, such as conventional or ultramarathons as well as extreme bike road races, may be related to new findings that suggest the activities are addicting. Researchers discovered rats given a drug that produces withdrawal in ... ...

Severe sleep apnea can increase the risk of premature death compared with people without the sleep disorder, U.S. researchers say.

A Policy Forum published in this week's open access journal PLoS Medicine argues that twenty-five years of health care reforms in Mexico have increased insurance coverage but have not resulted in greater efficiency and have not significantly reduced health inequities despite their costs in a country that has huge divisions between the rich and the poor.

Severe breathing disorders during sleep are associated with an increased risk of dying from any cause according to research published this week in the open access journal PLoS Medicine. The study finds that the increased risk of dying is most apparent in men between 40 and 70 years of age with severe sleep-disordered breathing, and suggests a specific link between this condition and death from coronary heart disease in men.

Biochemistry, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable). (Source: Biochemistry)MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Microscopic magnetic particles have been used to bring stem cells to sites of cardiovascular injury in a new method designed to increase the capacity of cells to repair damaged tissue, UCL scientists haved announced.

Contrary to a belief widely held by obstetricians, inducing labor need not increase a woman's risk for cesarean section delivery in childbirth, scientists at the University of California, San Francisco and the Stanford University school of Medicine have found.